Por eso el mayor peligro que hay es que se haga un uso frvolo sin la supervisin de expertos"
Other than lowering blood sugar levels and reducing weight, studies show that GLP-1 agonists may have other potential benefits, like: The most common side effects of GLP-1 agonists include: These side effects are more likely to happen when you start the medication or if youre taking an increased dose
ProHealth BPC-157 is a dietary supplement, not a medication
Unlike prior meta-analyses predominantly focused on MCI and dementia, this review emphasizes feasibility, usability, and the integration of cognitive and physical tasks within VR interventions, offering new clinical insights relevant for early-stage intervention
It is important to distinguish between urinary changes related to GLP-1 therapy and those caused by other diabetes medications, particularly SGLT2 inhibitors (such as dapagliflozin, empagliflozin), which do directly increase urination as their primary mechanism of action
The STEP clinical trial programme, comprising 10 Phase 3 studies, produced the most comprehensive dataset on GLP-1R agonism in human obesity research